Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
FlexShopper Partners with Versatile Credit to Expand Merchant Opportunities
-
Protara Therapeutics Announces Results from THRIVE-1, a Prospective Observational Study Evaluating the Prevalence of Choline Deficiency and Liver Injury in Patients Dependent on Parenteral Support
-
Replimune Announces Positive Pre-BLA Meeting with FDA and Confirms BLA Submission On Track for 2H 2024
-
Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia
-
Joint Commission International, in Collaboration with Geneva Sustainability Centre, Launches New Healthcare Sustainability Certification
-
StarTree Achieves 80% Customer Growth and 90% Revenue Increase H1 FY25, On Track to Double Customer Base by Year-End
-
Excision BioTherapeutics Announces Oral Presentation at the 2024 International HBV Meeting
-
Annual rankings show improvements in EV public charging infrastructure but highlights persistent gaps across the US
-
SMC Entertainment Enters Letter of Intent to Acquire Boutique Investment Manager, Bateau Asset Management, Providing Entry to Australian and Southeast Asian Financial Services Market
-
ProStar Holdings Announces Non-Brokered Private Placement
-
Smart For Life Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
-
VERB’s MARKET.live Launches Groundbreaking Pinterest Technology Integration
-
Power Engineers Shareholders Approve Acquisition by WSP
-
Upstream Bio Announces Oral Presentation of New Data from a Phase 1b Multiple Ascending Dose Trial of Verekitug (UPB-101) in Adults with Asthma at the European Respiratory Society Congress
-
CytomX Therapeutics Announces First Patient Dosed with CX-801, a Dually-Masked Interferon-Alpha 2b PROBODY®, in a Phase 1 Study in Patients with Solid Tumors
-
14 Ways To Transform Your IR Webcasts
-
Actuate Therapeutics Obtains Complete Responses and Provides Update on Clinical Trial of Elraglusib for the Treatment of Relapsed/Refractory Ewing Sarcoma
-
Bitget's Protection Fund Maintains Above Commitment at $390M in August 2024 Despite Market Turbulence
-
Core-Backbone Upgrades Key Network Routes in Germany with Infinera’s GX Series Solution
-
BioAtla Announces Upcoming Poster Presentation at the 2024 European Society for Medical Oncology (ESMO) Annual Meeting
-
Tricolor Opens State-of-the-Art Automotive Reconditioning Facility In Surprise, Arizona
-
PodcastOne Names Steve Lehman Vice Chairman to Drive Its Mergers, Acquisitions and Strategy Efforts
-
ORYZON Announces First Patient Dosed in an Investigator-Initiated Phase Ib Study of Iadademstat in First-Line Acute Myeloid Leukemia
-
World First: TMC and PAMCO Achieve Breakthrough in Commercial-Scale Processing of Polymetallic Nodules, Successfully Producing Calcine
-
Gabelli Funds to Host 2nd Annual PFAS Symposium at The Harvard Club, New York, NY
-
Mudra Link by Wearable Devices: The First Neural Interface Wristband for Android Users, Now Available for Pre-Order
-
Lotus Eletre SUV Starts Delivery in North Asia
-
LIS Technologies Inc. Appoints Former 33rd Assistant Commandant of the Marine Corps General John M. Paxton Jr. USMC (Ret.) as its Executive Chair of Military and Defense.
-
ALX Oncology to Present at the 2024 Cantor Fitzgerald Global Healthcare Conference
-
Akur8 Expands Core Capabilities with Strategic Acquisition of Arius® Reserving Solution
-
Annexon to Present Phase 2 ARCHER Data on Protection of Vision and Photoreceptors with ANX007 in GA at the Retina Society 57th Annual Meeting and 24th Euretina Congress
-
Accredited Solutions Files $3.6M Reg A Offering to Support Acquisition Strategy and Growth Initiatives
-
Rubicon Organics Announces Board Appointment and DSU Grant
-
Ocean Power Technologies Completes New WAM-V for Immediate Delivery to Latin America
-
Lisata Therapeutics to Participate in Upcoming September 2024 Industry and Investor Events
-
SINTX Receives Notice of Allowance for United States Patent Application for Silicon Nitride-Functionalized Zirconia-Toughened Alumina Ceramic Biomaterial
-
Casella Waste Systems, Inc. to Acquire Royal Carting and Welsh Sanitation
-
FOREWARN Partners with Howard County Association of REALTORS®
-
Sauce Essentials Transitions to 1.25g All-In-One Vapes in California, Bringing Consumers More Value for the Same Price
-
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
-
Heliene and OMCO Solar Launch New Module and Racking Solution To Gain American Manufacturing Benefits
-
Biora Therapeutics Achieves ISO 13485 Certification
-
PodcastOne Names Steve Lehman Vice Chairman to Drive Its Mergers, Acquisitions and Strategy Efforts
-
Evaxion reports 69% Overall Response Rate in its phase 2 trial on lead cancer vaccine candidate EVX-01
-
Velcan Holdings: Share buyback program - weekly statement
-
Technip Energies appoints new Managing Director for Americas
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
RIGImmune Announces Multiple Oral Presentations for Intranasal RIG-101 at European Respiratory Society Congress 2024
-
BriaCell Announces Presentation at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
-
China’s Private “Starlink” Achieves Nearly Half Deployment, Launches Global Commercial Services
